BiggsR.: Human Blood Coagulation, Haemostasis and Thrombosis, 1st ed., Blackwell Scientific Publications, Osney Mead, Oxford, 1972, p. 518.
3.
AppleW. S.: Evaluation of Drug Interactions, 2nd Ed., American Pharmaceutical Association, Washington, D.C. 20037, 1976, pp. 307–326.
4.
CheinY. W.: Comparative Binding of Disopyramide Phosphate and Quinidine Sulfate in Human Plasma Proteins, J. Pharm. Sci.63: 1877–1879, 1974.
5.
HinderlingP. H.: Protein Binding and Erythrocyte Partitioning of Disopyramide and Its Mono-dealkylated Metabolite, J. Pharm. Sci.63: 1684–1690, 1974.
6.
Personal Communication with Dr. Strathman, Director of Drug Surveillance, Searle Laboratories, 1979.
7.
AttwoodH. D.DennettX.: A Black Thyroid and Minocycline Treatment, Br. Med. J.4: 1109–1110, 1976.
8.
BenitzK. F.: Morphologic Effects of Minocycline in Laboratory Animals, Toxicol. Appl. Pharmacol.11: 150–170, 1967.
9.
SaitoK.: Studies on Goitrogenic Action of Minocycline and Related Compounds, Endocrinol.90: 1192–1201, 1972.
10.
CalesnickB.: The Antithyroid Action of Antibiotics, Science119: 128–129, 1954.
11.
KellyR. G.: Metabolism and Tissue Distribution of Radioisotopically Labeled Minocycline, Toxicol. Appl. Pharmacol.11: 174–183, 1967.
12.
Anon.: Physicians Desk Reference, 33rd Ed., Medical Economics, Oradel, New Jersey, 1979, p. 971.
13.
HanstenP. D.: Drug Interactions, 3rd Ed., Lea and Febiger, Philadelphia, Pa., 1975, pp. 326–331.
14.
GoodwinF. K.: Lithium in Mania and Depression: A Double-Blind Behavioral and Biochemical Study. Presented at the Annual Meeting of the American Psychiatric Association, Boston, May 16, 1968. Ibid. Hansten, P. D.
15.
HicklerR. B.ThornG. W.: Pheochromocytoma, Principles of Internal Medicine, 8th Ed., McGraw-Hill, New York, 1977, p. 563.
16.
Personal Communication, Alice Lynn, Steroid Division, Solano Laboratories, October 1978.
17.
YoungD. S.PestanerL. C.GibbermanV.: Clinical Chemistry Effects of Drugs on Clinical Laboratory Test, Clin. Chemistry25: 3880, 1975.
18.
BardfeldP. A.: A Controlled Double-Blind Study of Trimethobenzamide, Prochlorperazine and Placebo, J. Am. Med. Assoc.196: 116–148 (May 30) 1966.
19.
BellvilleJ. W.BrossI. D. S.HowlandW. S.: Postoperative Nausea and Vomiting — Antiemetic Efficacy of Trimethobenzamide and Perphenazine, Clin. Pharmacol. Ther.1: 590–596 (Sept.-Oct.) 1960.
20.
BlatchfordE.: Studies of Antiemetic Drugs — A Comparative Study of Cyclizine, Pipamazine, Trimethobenzamide and Hyoscine, Can. Anaes. Soc. J.8: 159–165 (Mar.) 1961.
21.
MoertelC. G.ReitemeierR. J.GageR. P.: A Controlled Clinical Evaluation of Antiemetic Drugs, J. Am. Med. Assoc.186: 116–118 (Oct.) 1963.
22.
Personal Communication, Dr. Arthur Shinn, Beecham Laboratories, 1979.
23.
LogothetisJ.: Spontaneous Epileptic Seizures and Electroencephalographic Changes in the Course of Phenothiazine Therapy, Neurol.17: 869–877 (Sept.) 1967.
24.
Boston Collaborative Drug Surveillance Program: Drug-Induced Convulsions, Lancet2: 277–279 (Sept. 30) 1972.
25.
Personal Communication, Dr. Desmond Simon, Winthrop Laboratories, 1979.
26.
EldevikO. P.NakkenK. O.HaughtonV. M.: The Effect of Dehydration on the Side Effects of Metrizamide Myelography, Radiol.129: 715–716 (Dec.) 1978.